Skip to main content
SpringerLink
Log in

Role of PET/MR in Squamous Cell Cancer Staging

  • Chapter
  • First Online:
Hybrid PET/MR Neuroimaging

  • 1774 Accesses

Abstract

Squamous cell cancer accounts for most head and neck cancers arising from the squamous lining of the upper aerodigestive tract. Staging, nodal spread, treatment, and prognosis vary with the site of origin. Historically, the risk factors include cigarette smoking and alcohol consumption; however, in recent decades, there is an overall increasing incidence of human papillomavirus-related squamous cell cancer that carries a better prognosis and is more responsive to chemoradiation therapy. Imaging plays a very important role in diagnosis, staging, treatment planning, prognostication, and follow-up of these tumors. Head and neck cancer is one of the promising indications for PET/MRI, given the fact that complete evaluation of these tumors usually requires both PET/CT and MRI.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.

    Article  Google Scholar 

  2. Chow LQM. Head and neck cancer. N Engl J Med. 2020;382(1):60–72.

    Article  CAS  PubMed  Google Scholar 

  3. Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29(32):4294–301.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Chaturvedi AK, Graubard BI, Broutian T, Pickard RKL, Tong ZY, Xiao W, et al. Effect of prophylactic human papillomavirus (HPV) vaccination on Oral HPV infections among young adults in the United States. J Clin Oncol. 2018;36(3):262–7.

    Article  CAS  PubMed  Google Scholar 

  5. Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging. CA Cancer J Clin. 2017;67(2):93–9.

    Article  PubMed  Google Scholar 

  6. Glastonbury CM. Critical changes in the staging of head and neck cancer. Radiol Imaging Cancer. 2020;2(1):e190022.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Lydiatt W, O'Sullivan B, Patel S. Major changes in head and neck staging for 2018. Am Soc Clin Oncol Educ Book. 2018;38:505–14.

    Article  PubMed  Google Scholar 

  8. Goel R, Moore W, Sumer B, Khan S, Sher D, Subramaniam RM. Clinical practice in PET/CT for the management of head and neck squamous cell cancer. AJR Am J Roentgenol. 2017;209(2):289–303.

    Article  PubMed  Google Scholar 

  9. Kuhn FP, Hüllner M, Mader CE, Kastrinidis N, Huber GF, von Schulthess GK, et al. Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed? Journal of nuclear medicine. 2014;55(4):551–8.

    Article  CAS  PubMed  Google Scholar 

  10. Lee YZ, Ramalho J, Kessler B. PET-MR imaging in head and neck. Magn Reson Imaging Clin N Am. 2017;25(2):315–24.

    Article  PubMed  Google Scholar 

  11. Misono S, Rue T, Rajendran J, Davis GE. Effects of upstaging from PET scan on survival in head and neck squamous cell carcinoma. Head Neck. 2010;32(10):1283–7.

    Article  PubMed  Google Scholar 

  12. Hustinx R, Smith RJ, Benard F, Rosenthal DI, Machtay M, Farber LA, et al. Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck. Eur J Nucl Med. 1999;26(10):1345–8.

    Article  CAS  PubMed  Google Scholar 

  13. Houshmand S, Salavati A, Basu S, Khiewvan B, Alavi A. The role of dual and multiple time point imaging of FDG uptake in both normal and disease states. Clin Transl Imaging. 2014;2(4):281–93.

    Article  Google Scholar 

  14. Davis AJ, Rehmani R, Srinivasan A, Fatterpekar GM. Perfusion and permeability imaging for head and neck cancer: theory, acquisition, Postprocessing, and relevance to clinical imaging. Magn Reson Imaging Clin N Am. 2018;26(1):19–35.

    Article  PubMed  Google Scholar 

  15. Lee FK, King AD, Ma BB, Yeung DK. Dynamic contrast enhancement magnetic resonance imaging (DCE-MRI) for differential diagnosis in head and neck cancers. Eur J Radiol. 2012;81(4):784–8.

    Article  PubMed  Google Scholar 

  16. Kabadi SJ, Fatterpekar GM, Anzai Y, Mogen J, Hagiwara M, Patel SH. Dynamic contrast-enhanced MR imaging in head and neck cancer. Magn Reson Imaging Clin N Am. 2018;26(1):135–49.

    Article  PubMed  Google Scholar 

  17. Donaldson SB, Betts G, Bonington SC, Homer JJ, Slevin NJ, Kershaw LE, et al. Perfusion estimated with rapid dynamic contrast-enhanced magnetic resonance imaging correlates inversely with vascular endothelial growth factor expression and pimonidazole staining in head-and-neck cancer: a pilot study. Int J Radiat Oncol Biol Phys. 2011;81(4):1176–83.

    Article  PubMed  Google Scholar 

  18. Pasha MA, Marcus C, Fakhry C, Kang H, Kiess AP, Subramaniam RM. FDG PET/CT for management and assessing outcomes of squamous cell cancer of the oral cavity. AJR Am J Roentgenol. 2015;205(2):W150–61.

    Article  PubMed  Google Scholar 

  19. Sekine T, de Galiza BF, Kuhn FP, Burger IA, Stolzmann P, Huber GF, et al. PET+MR versus PET/CT in the initial staging of head and neck cancer, using a trimodality PET/CT+MR system. Clin Imaging. 2017;42:232–9.

    Article  PubMed  Google Scholar 

  20. Sekine T, Barbosa FG, Delso G, Burger IA, Stolzmann P, Ter Voert EE, et al. Local resectability assessment of head and neck cancer: positron emission tomography/MRI versus positron emission tomography/CT. Head Neck. 2017;39(8):1550–8.

    Article  PubMed  Google Scholar 

  21. Eggesbo HB. Imaging of sinonasal tumours. Cancer Imaging. 2012;12:136–52.

    Article  PubMed  Google Scholar 

  22. Kılıç S, Kılıç SS, Kim ES, Baredes S, Mahmoud O, Gray ST, et al. Significance of human papillomavirus positivity in sinonasal squamous cell carcinoma. Int Forum Allergy Rhinol. 2017;7(10):980–9.

    Article  PubMed  Google Scholar 

  23. Wang XY, Yan F, Hao H, Wu JX, Chen QH, Xian JF. Improved performance in differentiating benign from malignant sinonasal tumors using diffusion-weighted combined with dynamic contrast-enhanced magnetic resonance imaging. Chin Med J. 2015;128(5):586–92.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Kanda T, Kitajima K, Suenaga Y, Konishi J, Sasaki R, Morimoto K, et al. Value of retrospective image fusion of 18F-FDG PET and MRI for preoperative staging of head and neck cancer: comparison with PET/CT and contrast-enhanced neck MRI. Eur J Radiol. 2013;82(11):2005–10.

    Article  PubMed  Google Scholar 

  25. Brennan B. Nasopharyngeal carcinoma. Orphanet J Rare Dis. 2006;1:23.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Petersson F. Nasopharyngeal carcinoma: a review. Semin Diagn Pathol. 2015;32(1):54–73.

    Article  PubMed  Google Scholar 

  27. Tsao SW, Tsang CM, Lo KW. Epstein-Barr virus infection and nasopharyngeal carcinoma. Philos Trans R Soc Lond Ser B Biol Sci. 2017;372(1732):20160270.

    Article  Google Scholar 

  28. Stenmark MH, McHugh JB, Schipper M, Walline HM, Komarck C, Feng FY, et al. Nonendemic HPV-positive nasopharyngeal carcinoma: association with poor prognosis. Int J Radiat Oncol Biol Phys. 2014;88(3):580–8.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Chen WS, Li JJ, Hong L, Xing ZB, Wang F, Li CQ. Comparison of MRI, CT and 18F-FDG PET/CT in the diagnosis of local and metastatic of nasopharyngeal carcinomas: an updated meta analysis of clinical studies. Am J Transl Res. 2016;8(11):4532–47.

    PubMed  PubMed Central  Google Scholar 

  30. Mohandas A, Marcus C, Kang H, Truong MT, Subramaniam RM. FDG PET/CT in the management of nasopharyngeal carcinoma. AJR Am J Roentgenol. 2014;203(2):W146–57.

    Article  PubMed  Google Scholar 

  31. Rumboldt Z, Gordon L, Bonsall R, Ackermann S. Imaging in head and neck cancer. Curr Treat Options in Oncol. 2006;7(1):23–34.

    Article  Google Scholar 

  32. Huang SH, Chien CY, Lin WC, Fang FM, Wang PW, Lui CC, et al. A comparative study of fused FDG PET/MRI, PET/CT, MRI, and CT imaging for assessing surrounding tissue invasion of advanced buccal squamous cell carcinoma. Clin Nucl Med. 2011;36(7):518–25.

    Article  PubMed  Google Scholar 

  33. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30.

    Article  PubMed  Google Scholar 

  34. Parvathaneni U, Lavertu P, Gibson MK, Glastonbury CM. Advances in diagnosis and multidisciplinary management of oropharyngeal squamous cell carcinoma: state of the art. Radiographics. 2019;39(7):2055–68.

    Article  PubMed  Google Scholar 

  35. Cantrell SC, Peck BW, Li G, Wei Q, Sturgis EM, Ginsberg LE. Differences in imaging characteristics of HPV-positive and HPV-negative oropharyngeal cancers: a blinded matched-pair analysis. AJNR Am J Neuroradiol. 2013;34(10):2005–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Zapanta PE. Neck cancer, Unknown Primary Site.

    Google Scholar 

  37. Christenson J, Li RJ. Management of unknown primary cancer of the head and neck. In: Difficult decisions in head and neck oncologic surgery. Springer; 2019. p. 91–103.

    Chapter  Google Scholar 

  38. Miller FR, Karnad AB, Eng T, Hussey DH, Stan McGuff H, Otto RA. Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy. Head Neck. 2008;30(1):28–34.

    Article  PubMed  Google Scholar 

  39. Rusthoven KE, Koshy M, Paulino AC. The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor. Cancer. 2004;101(11):2641–9.

    Article  PubMed  Google Scholar 

  40. Johansen J, Buus S, Loft A, Keiding S, Overgaard M, Hansen HS, et al. Prospective study of 18FDG-PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA-13 study. Head Neck. 2008;30(4):471–8.

    Article  PubMed  Google Scholar 

  41. Rudmik L, Lau HY, Matthews TW, Bosch JD, Kloiber R, Molnar CP, et al. Clinical utility of PET/CT in the evaluation of head and neck squamous cell carcinoma with an unknown primary: a prospective clinical trial. Head Neck. 2011;33(7):935–40.

    Article  PubMed  Google Scholar 

  42. Sekine T, Barbosa FG, Sah BR, Mader CE, Delso G, Burger IA, et al. PET/MR outperforms PET/CT in suspected occult tumors. Clin Nucl Med. 2017;42(2):e88–95.

    Article  PubMed  Google Scholar 

  43. Hermans R. Imaging of hypopharyngeal and cervical oesophageal cancer. Cancer Imaging. 2003;4(1):7–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Novacek G. Plummer-Vinson syndrome. Orphanet J Rare Dis. 2006;1:36.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Chan SC, Yeh CH, Yen TC, Ng SH, Chang JT, Lin CY, et al. Clinical utility of simultaneous whole-body. Eur J Nucl Med Mol Imaging. 2018;45(8):1297–308.

    Article  PubMed  Google Scholar 

  46. Plaxton NA, Brandon DC, Corey AS, Harrison CE, Karagulle Kendi AT, Halkar RK, et al. Characteristics and limitations of FDG PET/CT for imaging of squamous cell carcinoma of the head and neck: a comprehensive review of anatomy, metastatic pathways, and image findings. AJR Am J Roentgenol. 2015;205(5):W519–31.

    Article  PubMed  Google Scholar 

  47. Banko B, Dukić V, Milovanović J, Kovač JD, Artiko V, Maksimović R. Diagnostic significance of magnetic resonance imaging in preoperative evaluation of patients with laryngeal tumors. Eur Arch Otorhinolaryngol. 2011;268(11):1617–23.

    Article  PubMed  Google Scholar 

  48. Chung MS, Choi YJ, Kim SO, Lee YS, Hong JY, Lee JH, et al. A scoring system for prediction of cervical lymph node metastasis in patients with head and neck squamous cell carcinoma. AJNR Am J Neuroradiol. 2019;40(6):1049–54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Emmett L, Lee J, Tang R, Ho B. Impact of small node size on clinical interpretation of F18 FDG PET CT for primary head and neck SCC malignancy. Bad things can come in small packages. J Nucl Med. 2017;58(supplement 1):217.

    Google Scholar 

  50. Toya R, Saito T, Matsuyama T, Kai Y, Shiraishi S, Murakami D, et al. Diagnostic value of FDG-PET/CT for the identification of extranodal extension in patients with head and neck squamous cell carcinoma. Anticancer Res. 2020;40(4):2073–7.

    Article  CAS  PubMed  Google Scholar 

  51. Hiyama T, Kuno H, Nagaki T, Sekiya K, Oda S, Fujii S, et al. Extra-nodal extension in head and neck cancer: how radiologists can help staging and treatment planning. Jpn J Radiol. 2020;38(6):489–506.

    Article  PubMed  Google Scholar 

  52. Kimura Y, Sumi M, Sakihama N, Tanaka F, Takahashi H, Nakamura T. MR imaging criteria for the prediction of extranodal spread of metastatic cancer in the neck. AJNR Am J Neuroradiol. 2008;29(7):1355–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Kim SG, Friedman K, Patel S, Hagiwara M. Potential role of PET/MRI for imaging metastatic lymph nodes in head and neck cancer. AJR Am J Roentgenol. 2016;207(2):248–56.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Jansen JFA, Parra C, Lu Y, Shukla-Dave A. Evaluation of head and neck tumors with functional MR imaging. Magn Reson Imaging Clin N Am. 2016;24(1):123–33.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Fischbein NJ, Noworolski SM, Henry RG, Kaplan MJ, Dillon WP, Nelson SJ. Assessment of metastatic cervical adenopathy using dynamic contrast-enhanced MR imaging. AJNR Am J Neuroradiol. 2003;24(3):301–11.

    PubMed  PubMed Central  Google Scholar 

  56. Shukla-Dave A, Lee NY, Jansen JF, Thaler HT, Stambuk HE, Fury MG, et al. Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases. Int J Radiat Oncol Biol Phys. 2012;82(5):1837–44.

    Article  PubMed  Google Scholar 

  57. Haerle SK, Schmid DT, Ahmad N, Hany TF, Stoeckli SJ. The value of (18)F-FDG PET/CT for the detection of distant metastases in high-risk patients with head and neck squamous cell carcinoma. Oral Oncol. 2011;47(7):653–9.

    Article  PubMed  Google Scholar 

  58. Chen YJ, Rath T, Mohan S. PET-computed tomography in head and neck cancer: current evidence and future directions. Magn Reson Imaging Clin N Am. 2018;26(1):37–49.

    Article  PubMed  Google Scholar 

  59. Ferlito A, Shaha AR, Silver CE, Rinaldo A, Mondin V. Incidence and sites of distant metastases from head and neck cancer. ORL J Otorhinolaryngol Relat Spec. 2001;63(4):202–7.

    Article  CAS  PubMed  Google Scholar 

  60. Szyszko TA, Cook GJR. PET/CT and PET/MRI in head and neck malignancy. Clin Radiol. 2018;73(1):60–9.

    Article  CAS  PubMed  Google Scholar 

  61. Rice SL, Friedman KP. Clinical PET-MR imaging in breast cancer and lung cancer. PET Clin. 2016;11(4):387–402.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Melsaether A, Moy L. Breast PET/MR imaging. Radiol Clin N Am. 2017;55(3):579–89.

    Article  PubMed  Google Scholar 

  63. Partovi S, Kohan A, Vercher-Conejero JL, Rubbert C, Margevicius S, Schluchter MD, et al. Qualitative and quantitative performance of 18F-FDG-PET/MRI versus 18F-FDG-PET/CT in patients with head and neck cancer. AJNR Am J Neuroradiol. 2014;35(10):1970–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Stolzmann P, Veit-Haibach P, Chuck N, Rossi C, Frauenfelder T, Alkadhi H, et al. Detection rate, location, and size of pulmonary nodules in trimodality PET/CT-MR: comparison of low-dose CT and Dixon-based MR imaging. Investig Radiol. 2013;48(5):241–6.

    Article  Google Scholar 

  65. Platzek I. (18)F-Fluorodeoxyglucose PET/MR imaging in head and neck cancer. PET Clin. 2016;11(4):375–86.

    Article  PubMed  Google Scholar 

  66. Raad RA, Friedman KP, Heacock L, Ponzo F, Melsaether A, Chandarana H. Outcome of small lung nodules missed on hybrid PET/MRI in patients with primary malignancy. J Magn Reson Imaging. 2016;43(2):504–11.

    Article  PubMed  Google Scholar 

  67. Rohde M, Nielsen AL, Johansen J, Sørensen JA, Nguyen N, Diaz A, et al. Head-to-head comparison of chest X-ray/head and neck MRI, chest CT/head and neck MRI, and. J Nucl Med. 2017;58(12):1919–24.

    Article  CAS  PubMed  Google Scholar 

  68. Rischin D, Hicks RJ, Fisher R, Binns D, Corry J, Porceddu S, et al. Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of trans-tasman radiation oncology group study 98.02. J Clin Oncol. 2006;24(13):2098–104.

    Article  PubMed  Google Scholar 

  69. Eisenmenger LB. Non-FDG radiopharmaceuticals in head and neck PET imaging: current techniques and future directions. Semin Ultrasound CT MR. 2019;40(5):424–33.

    Article  PubMed  Google Scholar 

  70. Kaur S, Venktaraman G, Jain M, Senapati S, Garg PK, Batra SK. Recent trends in antibody-based oncologic imaging. Cancer Lett. 2012;315(2):97–111.

    Article  CAS  PubMed  Google Scholar 

  71. Queiroz MA, Huellner MW. PET/MR in cancers of the head and neck. Semin Nucl Med. 2015;45(3):248–65.

    Article  PubMed  Google Scholar 

  72. Kalemaki MS, Karantanas AH, Exarchos D, Detorakis ET, Zoras O, Marias K, et al. PET/CT and PET/MRI in ophthalmic oncology (review). Int J Oncol. 2020;56(2):417–29.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, University of Alabama at Birmingham (UAB), Birmingham, AL, USA

    Gagandeep Choudhary & Houman Sotoudeh

Authors
  1. Gagandeep Choudhary
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Houman Sotoudeh
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, The Feinstein Institutes for Medical Research, Manhasset, NY, USA

    Ana M. Franceschi

  2. Stony Brook University Hospital, Stony Brook, NY, USA

    Dinko Franceschi

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Choudhary, G., Sotoudeh, H. (2022). Role of PET/MR in Squamous Cell Cancer Staging. In: Franceschi, A.M., Franceschi, D. (eds) Hybrid PET/MR Neuroimaging. Springer, Cham. https://doi.org/10.1007/978-3-030-82367-2_55

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-82367-2_55

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-82366-5

  • Online ISBN: 978-3-030-82367-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation